ABSTRACT
INTRODUCTION
Although the overall prevalence of pulmonary tuberculosis (TB) has decreased, it remains an important cause of morbidity and mortality.
1 Multidrug-resistant TB (MDR TB) has surged as a public health problem worldwide. 2 The major concerns of drug resistance are fear regarding the spread of drug-resistant organisms and the ineffectiveness of anti-microbial treatment in patients infected with these organisms. Lockman et al 3 suggested that human immunodeficiency virus (HIV)-negative patients with primary MDR TB have significantly higher treatment failure rates and higher mortality compared with those with drug-sensitive TB.
Diagnosing pulmonary TB is usually based on detecting acid-fast bacilli in sputum smears or cultures. In addition to the diagnosis of TB, high-resolution computed tomography (CT) is useful for determining disease activity. 4, 5 Cavities, the radiological hallmark of reactivated TB, are evident radiographically in 40% to 45% of patients with post-primary TB. 6, 7 Multiple cavities are seen more frequently in patients with MDR TB. 8, 9 The majority of cavities heal as linear or fibrotic lesions, but some cavities persist after anti-tuberculous therapy. Thus, it can be difficult to determine pulmonary TB activity on imaging studies when cavities persist after anti-tuberculous therapy. The purpose of this study was to determine how to differentiate inactive from active disease in patients with primary MDR TB who had a persistent cavity after completing treatment.
METHODS

Patients and Diagnoses
Our institutional review board approved this retrospective study with a waiver of the requirement for informed patient consent.
A computer-based search was performed to identify patients with pulmonary MDR TB from September 2005 to March 2013. Inclusion criteria for this study were: (1) bacteriologically confirmed TB with positive sputum culture of Mycobacterium tuberculosis; and (2) newly diagnosed primary MDR TB (defined as TB resistant to at least isoniazid and rifampicin); the mode of acquisition of drug resistance was defined as 'primary' when it was identified in an individual who had never received anti-tuberculous therapy or who had a therapy history of <1 month; radiological findings might show inadvertently progressed features with an ongoing infection (chronic TB infection) during the development of acquired resistance; thus, we only included patients who had a primary resistant form of MDR TB; (3) 
Image Acquisition and Analysis
All CT examinations were performed using a four-row multidetector CT scanner (Asteion; Toshiba Medical, Tokyo, Japan). None of the patients were administered any intravenous contrast medium. Thin-section CT scans were performed from the lung apices to the lung bases with a 1-mm collimation at 10-mm intervals. The thin-section scanning parameters were 120 kV with a 512 × 512 matrix. Data were reconstructed using a 2.5-mm thickness for transaxial images.
Chest CT scans were reviewed by two radiologists (SHK and JYL) with 4 and 15 years of experience respectively, and both had no knowledge of the patients' clinical information. A final decision regarding the findings was determined by consensus.
The assessed patterns of parenchymal abnormalities included cavity (site, number, size of the largest cavity, and the maximal thickness), centrilobular nodules (including a tree-in-bud pattern), consolidation, large nodules (a well-defined nodule 10-30 mm in diameter), calcified nodules, parenchymal calcification, paracicatricial emphysema, bronchovascular distortion, irregular lines, and a parenchymal band (a linear opacity that usually extends to the visceral pleura). The laterality (unilateral or bilateral) of cavities was also analysed.
We measured cavity wall thickness at the thickest portion. In addition, the presence of mediastinal or hilar lymph node enlargement and pleural effusion or thickening was recorded. Enlarged lymph nodes were defined as those having a short-axis diameter of >1 cm on CT scan.
Statistical Analyses
Statistical analyses were performed using the SPSS 19.0 software (SPSS, Inc., Chicago, IL, USA). The mean age and sex ratios of the patients with TB were evaluated using the Mann-Whitney U test and the chi-square test, respectively. The CT findings in patients with TB were compared with the chi-square and Fisher's exact tests. The Mann-Whitney U test was used to test the number, size, and thickness of cavities. A logistic regression was performed for the multivariate analysis. A p value of <0.05 was considered statistically significant.
RESULTS
The demographic data of the two groups are summarised in Table 1 . No significant differences in age or sex were observed between the groups with chronic inactive and active cavitary MDR TB. The CT findings of the two groups are summarised in Inactive TB (n = 31) Active TB (n = 31) Table 2 . Comparison of the computed tomography findings for inactive and active primary multidrug-resistant tuberculosis with a persistent cavity after anti-tuberculous therapy.
Abbreviation: TB = tuberculosis.
(a) (b)
the cavity wall (OR = 0.701; 95% CI, 0.503-0.988; p = 0.042) were significant CT findings in the chronic inactive cavitary group.
DISCUSSION
It is often necessary to determine pulmonary TB disease activity at treatment completion before the results of TB cultures are available. The decision must be based on clinical and radiological evidence. In this situation, a persistent cavity on imaging studies may cause confusion regarding treatment completion.
Tuberculous cavitation usually indicates a high likelihood of activity. 10 However, disease activity cannot be determined based on a cavity alone. Zierski
11
reported no bacteriological relapse for up to 5 years after anti-tuberculous therapy was stopped in patients who had a persistent cavity and a negative sputum culture, if adequate therapy was administered for a long period of time.
In this study, we evaluated CT findings to determine the activity of chronic cavitary disease in patients with primary MDR TB at the time of treatment completion. The most common CT findings of active pulmonary TB are centrilobular small nodules, branching linear and nodular opacities (tree-in-bud sign), patchy or lobular areas of consolidation and cavitation. 12 In our study, centrilobular nodules were significant CT findings associated with active disease in the multivariate analysis. Im et al 13 showed that small airway changes are the most characteristic findings of tuberculous infection. Small centrilobular nodules and the tree-in-bud sign reflect the presence of endobronchial spread and are due to the presence of caseous necrosis or granulomatous inflammation filling the surrounding terminal and respiratory bronchioles and alveolar ducts. 10 This appearance of the centrilobular nodules is highly suggestive of active TB but not pathognomonic for active TB. In the proper clinical setting, the centrilobular nodules are thought to be a reliable criterion for active disease. Coalescence of centrilobular opacity occurs with more extensive disease, resulting in focal areas of bronchopneumonia. In our study, consolidation was also less frequently observed in the chronic inactive cavitary group in the univariate analysis.
In our study, the cavity wall was thinner in the chronic inactive cavitary group than that in the chronic active cavitary group. Lee at al 14 reported that cavities could be a good diagnostic sign, but they found no specific correlation between the CT appearance of cavities and disease. However, active-disease cavities typically have thick, irregular walls that become smooth and thin with treatment.
15 Therefore, thickness of the cavity wall seems to be important for evaluating disease activity after completion of anti-tuberculous therapy.
No significant differences were observed between the two groups with respect to the presence of calcified nodules, parenchymal calcification, paracicatricial emphysema, bronchovascular distortion, fibrotic band, or pleural thickening. These findings may be due to the presence of residual fibrotic changes. Some patients in the sputum-positive group also showed these fibrotic changes. Im et al 13 showed that cavitary lesions cause
more cicatricial changes than other areas without cavitation following treatment, and that the prevalence of distortion of bronchovascular structures, emphysema, fibrotic bands, or bronchiectasis tend to increase on follow-up CT scans. Thus, fibrotic changes on CT may not be useful to differentiate between a chronic cavity and ongoing disease after anti-tuberculous therapy.
This study had some limitations. First, some selection bias may have occurred because not all patients with pulmonary TB underwent a CT scan. The evaluation of pulmonary TB involved sputum smear examination, sputum culture, and chest radiographs due to ease of performance, widespread availability, low cost, and a considerable diagnostic yield. CT scans were usually performed in patients with more grave symptoms and signs. Moreover, a chest CT scan was often performed in patients with cavitary TB for possible surgical treatment. 16 Therefore, this study was probably biased towards patients who were surgical candidates or had somewhat atypical clinical manifestations of TB. Second, the population studied was small and patients were recruited from only one hospital. As a result, this study population may not be representative of the general population. Additional investigations with larger populations are necessary. Third, we classified patients with MDR TB based on findings of sputum culture alone. Therefore, the 'chronic inactive cavitary MDR TB' group may have been wrongly classified, based upon a negative sputum culture, and no further testing, such as bronchoalveolar lavage, was used. In practice, as bronchoscopy examination is very painful, many patients refuse this examination. In our study, the chronic inactive cavitary MDR TB group was followed up for at least 1 year after treatment. No relapses were observed during this period.
CONCLUSION
Centrilobular nodules and thickness of the cavity wall were the most characteristic CT findings to predict active disease in patients with chronic cavitary pulmonary MDR TB at the time of treatment completion. In the proper clinical setting, these CT findings could help decision-making for completing treatment in cases of chronic cavitary MDR TB after anti-tuberculous therapy.
